RAPT Therapeutics, Inc.
RAPTDelisted Mar 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001673772
RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in RAPT Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 106
- +12 vs. Q4 2022
- Shares held
- 33.3M
- +1.25M (+3.9%) vs. Q4 2022
- Total value
- $610.5M
- −$23.9M (−3.8%) vs. Q4 2022
- New holders
- 27
- 35 more added
- Sold out
- 15
- 28 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RAPT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 106 | $1.02B |
| Q3 2025 | 65 | $428.0M |
| Q2 2025 | 50 | $135.6M |
| Q1 2025 | 92 | $160.0M |
| Q4 2024 | 91 | $199.5M |
| Q3 2024 | 94 | $59.9M |
| Q2 2024 | 103 | $97.0M |
| Q1 2024 | 122 | $287.2M |
| Q4 2023 | 109 | $869.3M |
| Q3 2023 | 96 | $577.8M |
| Q2 2023 | 98 | $636.7M |
| Q1 2023 | 106 | $610.5M |
| Q4 2022 | 95 | $634.7M |
| Q3 2022 | 98 | $721.0M |
| Q2 2022 | 85 | $542.7M |
| Q1 2022 | 85 | $616.1M |
| Q4 2021 | 99 | $1.02B |
| Q3 2021 | 106 | $817.8M |
| Q2 2021 | 109 | $846.6M |
| Q1 2021 | 78 | $468.4M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding RAPT Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Signaturefd, LLC | 33 | $606 | 0.00% | 00.0% | Unchanged |
| Ellevest, Inc. | 30 | $551 | 0.00% | +30 | New |
| Allworth Financial LP | 20 | $367 | 0.00% | +20 | New |
| US Bancorp | 11 | $202 | 0.00% | −53−82.8% | Reduced |
| Nisa Investment Advisors, LLC | 18 | $0 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 22 | $0 | 0.00% | +22 | New |
| Braidwell LP | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −281,875−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −264,142−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −109,000−100.0% | Sold out |
| Cheyne Capital Management (UK) LLP | 0 | $0 | 0.00% | −71,828−100.0% | Sold out |
| Regents of the University of California | 0 | $0 | 0.00% | −34,926−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −32,422−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −28,553−100.0% | Sold out |
| Weiss Multi-Strategy Advisers LLC | 0 | $0 | 0.00% | −25,010−100.0% | Sold out |
| Pentwater Capital Management LP | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −12,617−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −10,474−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −676−100.0% | Sold out |
| Telemetry Investments, L.L.C. | – | – | – | – | Not filed |